Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
about
Overview of biological mechanisms and applications of three murine models of bone repair: closed fracture with intramedullary fixation, distraction osteogenesis, and marrow ablation by reamingBisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) projectUpdates in biological therapies for knee injuries: bone.Quantitative phenotyping of bone fracture repair: a review.Investigation and management of osteoporosis in aged trauma patients: a treatment algorithm adapted to the German guidelines for osteoporosisThe relation between bisphosphonate use and non-union of fractures of the humerus in older adults.Site specific effects of zoledronic acid during tibial and mandibular fracture repair.Systemic treatment with strontium ranelate accelerates the filling of a bone defect and improves the material level properties of the healing bone.Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosisLocal low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.Impaired Fracture Healing Caused by Deficiency of the Immunoreceptor Adaptor Protein DAP12.Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite--an animal model.Macrophages: Their Emerging Roles in Bone.Fixation stability dictates the differentiation pathway of periosteal progenitor cells in fracture repair.Special Review: Accelerating fracture repair in humans: a reading of old experiments and recent clinical trials.The rat model of femur fracture for bone and mineral research: An improved description of expected comminution, quantity of soft callus and incidence of complicationsZoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cellsFracture healing and drug therapies in osteoporosis.Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing.Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfectaSafety of long-term bisphosphonate therapy for the management of osteoporosis.Choosing a treatment for patients at the time a fracture is presented.Anti-osteoporosis therapy and fracture healing.Replacement, refinement, and reduction: necessity of standardization and computational models for long bone fracture repair in animals.Effect of osteoporosis medications on fracture healing.The effect of zoledronate during bone healing.Effect of parathyroid hormone on healing in osteoporotic fractures via a phospholipase C-independent pathway.Impaired Fracture Healing after Hemorrhagic Shock.Augmentation of autologous bone graft by a combination of bone morphogenic protein and bisphosphonate increased both callus volume and strength.Bisphosphonates and direct fracture healing: Area to be explored.Effects of combined therapy of alendronate and low-intensity pulsed ultrasound on metaphyseal bone repair after osteotomy in the proximal tibia of aged rats.Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model.Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model.The masquelet induced membrane technique with BMP and a synthetic scaffold can heal a rat femoral critical size defect.Bisphosphonate treatment delays stress fracture remodeling in the rat ulna.Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis.Earlier effect of alendronate in mouse metaphyseal versus diaphyseal bone healing.Low-magnitude high-frequency vibration (LMHFV) enhances bone remodeling in osteoporotic rat femoral fracture healing.BMP-2 delivered via sucrose acetate isobutyrate (SAIB) improves bone repair in a rat open fracture model.
P2860
Q26827481-F0ECD6AC-20ED-49A6-A6EF-06AC27FF1F5BQ27026618-66AC2977-7D13-45B3-A160-833152736EF7Q30401258-DBDF790C-A42E-43E7-9BF8-F835FC8CF8A5Q30406059-8E4FEC7A-04DF-4AEB-B81E-3561B343508FQ33781648-EB42F53E-63B9-41FF-8B9A-49B20F9B4948Q33914702-5E8E6986-5588-4452-8CC0-CA0DCECA3F5DQ34168384-E637C6A8-34D5-457D-930F-B21B5B69B24BQ34177629-E5606788-8EC9-4288-B7A3-5C87490880B8Q34393622-C1773D74-2B9C-4C04-A0DB-00A15B06AAD9Q34469883-C36D1437-214A-4606-8EE3-8FE6285400B0Q35157847-523C2D25-C4FD-4484-907E-8D8C360C814AQ35648310-68F9BEFD-77CD-4AC4-A75C-ACD44000991AQ35885329-ADDD7F83-8702-4498-A812-6C2445187E58Q36926240-DFE7603D-FE5C-41A6-AF79-5BB78F8F4E1EQ36965951-AE0093F2-3D62-4DD6-9BFA-41B04E0AA1A5Q37043890-E2D36AFB-F822-44CB-A0A7-EB9CBE77B0A3Q37095172-BC678BB3-4171-43C5-9A41-0A623307F3C6Q37139859-EFB82879-69E1-4D99-8677-4ED99326DCE1Q37430434-6BDEE537-9B16-440D-ACBE-8C2FB0256605Q37581504-6922ADF8-7431-4215-8105-684F61AE509EQ37722288-1DB152B0-F14C-4883-9EF9-705E0CDF6F62Q37866764-9B359E01-14DC-430D-9BBB-6B769121FF46Q37886780-4324F4B7-70F0-4383-A1A6-CA522534B65AQ38017621-0A995900-2326-498D-930E-77D8D32E6EFBQ38129027-A1878DAE-84D1-448C-8C25-03883F6BC28DQ38595303-59E65442-F550-49F2-A116-5F9254110070Q39600509-526512D9-AB62-4B2B-AB7B-87C64CEAD0F9Q42110404-2C4BBD7A-DDFB-4929-A1EF-8D1A96CEAC01Q42225214-EE70D8A3-7EB2-4560-928D-C485609A1DAAQ42262308-42C8D749-F3E2-454B-BB2C-2FAAA167C009Q43005214-1F8645F7-DF4F-4033-92B2-29621014D1ACQ43490377-3B65EE1C-0F69-4900-8A88-E951140E631AQ46280547-8031AF9D-14D8-4805-9116-8FC53AEFCC19Q46294640-D095404E-7005-4179-8F0E-E5E0109F3A8FQ47408564-052CA391-C844-4923-8739-BDFA42A41CD4Q50277512-102929F8-93B0-4D45-95C6-20A75B1E19CDQ51021761-BB77F532-4671-4201-B033-74F726FAC6CFQ51314485-E6AFC1C0-4503-4EEF-8767-E20118B2100EQ51487076-226FB453-C2E2-4E35-A73F-F29ECDA082C1Q51602469-14805A9C-6BE7-4AA9-977D-093FF4AC7A6D
P2860
Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Bolus or weekly zoledronic aci ...... ays in hard callus remodeling.
@ast
Bolus or weekly zoledronic aci ...... ays in hard callus remodeling.
@en
type
label
Bolus or weekly zoledronic aci ...... ays in hard callus remodeling.
@ast
Bolus or weekly zoledronic aci ...... ays in hard callus remodeling.
@en
prefLabel
Bolus or weekly zoledronic aci ...... ays in hard callus remodeling.
@ast
Bolus or weekly zoledronic aci ...... ays in hard callus remodeling.
@en
P2093
P1433
P1476
Bolus or weekly zoledronic aci ...... lays in hard callus remodeling
@en
P2093
Craig Godfrey
David G Little
Negin Amanat
Sukhdeep Dulai
Tamara Sztynda
P304
P356
10.1016/J.BONE.2008.05.019
P577
2008-06-03T00:00:00Z